Loading
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Latest filing published 26 May 2026 for Avalo Therapeutics, Inc.. Read the official filing
Filing timeline
BuySaleGarry Arthur Neil
Insider track record
Disclosed buys
4
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-65.3%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Garry Arthur Neil: trading record in brief
Garry Arthur Neil has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Avalo Therapeutics, Inc. and Arena Pharmaceuticals Inc. Over a trading history stretching from 10 June 2021 to 21 May 2026, the count stands at 11 filings.
The open-market record is one-sided, with 4 purchases worth €34k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 4 share grants and 2 option exercises.
A typical purchase (the median) is worth €7,817. Clusters matter here: 3 out of 4 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
The record was last updated on 26 May 2026 with a share grant in Avalo Therapeutics, Inc. The last insider purchase was made public on 13 June 2023, 1,223 days ago. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Garry Arthur Neil
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations11 total
100,200 shares0Common StockSEC:0001586785-26-000006:0
64,866 sharesCommon StockSEC:0001586785-26-000004:0
21,892 shares@ US$13.890.078% mcap60.4% of flowCommon StockSEC:0001586785-26-000004:1
64,867 sharesCommon StockSEC:0001578563-25-000197:0
17,787 shares@ US$8.4631.9% of flowCommon StockSEC:0001578563-25-000197:1
4,000 shares@ US$3.422.9% of flowCommon StockSEC:0001628280-23-021958:0
Canonical exit: 7 Sept 2023 (T+90)
2,083 shares@ US$4.422.0% of flowCommon StockSEC:0001628280-22-031725:0
Canonical exit: 9 Mar 2023 (T+90)
8,150 sharesCommon StockSEC:0001628280-22-005912:0
4,267 shares@ US$1.571.4% of flowCommon StockSEC:0001879785-21-000037:0
Canonical exit: 10 Mar 2022 (T+90)
3,067 shares0Common StockSEC:0001628280-21-012275:0
3,692 shares@ US$2.28100.0% of flowCommon StockSEC:0001192482-21-000501:0
Canonical exit: 8 Sept 2021 (T+90)
11 of 11 declarations
